Reduced hippocampal activity during encoding in cognitively normal adults carrying the APOE e{open}4 allele

Neuropsychologia

Volumn 49, Issue 9, 2011, Pages 2448-2455

  Adamson, Maheen M ^a,b   Hutchinson, J Benjamin ^c   Shelton, Amy L ^d   Wagner, Anthony D ^c   Taylor, Joy L ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

APOE e open 4; Hippocampus; Learning; Medial temporal lobe; Memory; Visuo spatial

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON4; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN ELECTROPHYSIOLOGY; COGNITION; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HETEROZYGOTE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; LEARNING; LINGUAL GYRUS; MALE; MENTAL TASK; NERVE CELL NETWORK; NORMAL HUMAN; VISUAL CORTEX;

AGED; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; DEPTH PERCEPTION; DISCRIMINATION LEARNING; FEMALE; FIXATION, OCULAR; HETEROZYGOTE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; PROTEIN ISOFORMS; REFERENCE VALUES;

EID: 79960172210     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2011.04.022     Document Type: Article

References (72)

1. Adamson M.M., Landy K.M., Duong S., Fox-Bosetti S., Ashford J.W., Murphy G.M., et al. Apolipoprotein E epsilon4 influences on episodic recall and brain structures in aging pilots. Neurobiology of Aging 2010, 31:1059-1063.
2. Alexander D.M., Williams L.M., Gatt J.M., Dobson-Stone C., Kuan S.A., Todd E.G., et al. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades. Biological Psychology 2007, 75:229-238.
3. Bassett S.S., Yousem D.M., Cristinzio C., Kusevic I., Yassa M.A., Caffo B.S., et al. Familial risk for Alzheimer's disease alters fMRI activation patterns. Brain 2006, 129:1229-1239.
4. Blair C.K., Folsom A.R., Knopman D.S., Bray M.S., Mosley T.H., Boerwinkle E. APOE genotype and cognitive decline in a middle-aged cohort. Neurology 2005, 64:268-276.
5. Bondi M.W., Houston W.S., Eyler L.T., Brown G.G. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 2005, 64:501-508.
6. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., et al. Patterns of brain activation in people at risk for Alzheimer's disease. New England Journal of Medicine 2000, 343:450-456.
7. Borghesani P.R., Johnson L.C., Shelton A.L., Peskind E.R., Aylward E.H., Schellenberg G.D., et al. Altered medial temporal lobe responses during visuospatial encoding in healthy APOE* 4 carriers. Neurobiology of Aging 2008, 29:981-991.
8. Braak H., Braak E. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiology of Aging 1997, 18:S85-88.
9. Brewer J.B., Zhao Z., Desmond J.E., Glover G.H., Gabrieli J.D. Making memories: Brain activity that predicts how well visual experience will be remembered. Science 1998, 281:1185-1187.
10. Buckner R.L., Wheeler M.E., Sheridan M.A. Encoding processes during retrieval tasks. Journal of Cognitive Neuroscience 2001, 13:406-415.
11. Burgess N., Maguire E.A., O'Keefe J. The human hippocampus and spatial and episodic memory. Neuron 2002, 35:625-641.
12. Caselli R.J., Dueck A.C., Osborne D., Sabbagh M.N., Connor D.J., Ahern G.L., et al. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. New England Journal of Medicine 2009, 361:255-263.
13. Cherbuin N., Leach L.S., Christensen H., Anstey K.J. Neuroimaging and APOE Genotype: A systematic qualitative review. Dementia and Geriatric Cognitive Disorders 2007, 24:348-362.
14. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
15. Csernansky J.G., Wang L., Joshi S., Miller J.P., Gado M., Kido D., et al. Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type. Neurology 2000, 55:1636-1643.
16. de Leon M.J., Mosconi L., Blennow K., DeSanti S., Zinkowski R., Mehta P.D., et al. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Annals of the New York Academy of Sciences 2007, 1097:114-145.
17. DeCarli C., Miller B.L., Swan G.E., Reed T., Wolf P.A., Carmelli D. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Archives in Neurology 2001, 58:643-647.
18. deIpolyi A.R., Rankin K.P., Mucke L., Miller B.L., Gorno-Tempini M.L. Spatial cognition and the human navigation network in AD and MCI. Neurology 2007, 69:986-997.
19. den Heijer T., Oudkerk M., Launer L.J., van Duijn C.M., Hofman A., Breteler M.M. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 2002, 59:746-748.
20. Dennis N.A., Browndyke J.N., Stokes J., Need A., Burke J.R., Welsh-Bohmer K.A., et al. Temporal lobe functional activity and connectivity in young adult APOE epsilon4 carriers. Alzheimers Dementia 2009.
21. Eichenbaum H. A cortical-hippocampal system for declarative memory. Nature Reviews Neuroscience 2000, 1:41-50.
22. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997, 278:1349-1356.
23. Filippini N., MacIntosh B.J., Hough M.G., Goodwin G.M., Frisoni G.B., Smith S.M., et al. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:7209-7214.
24. Fleisher A., Grundman M., Jack C.R., Petersen R.C., Taylor C., Kim H.T., et al. Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Archives of Neurology 2005, 62:953-957.
25. Fleisher A.S., Sherzai A., Taylor C., Langbaum J.B., Chen K., Buxton R.B. Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups. Neuroimage 2009, 47:1678-1690.
26. Geffen G. Normative data for the Auditory Verbal Learning Test. Personal communication cited in Spreen and Strauss. A compendium of neuropsychological tests: Administration, norms and commentary 1995, Oxford University Press, New York. 2nd ed.
27. Geroldi C., Pihlajamaki M., Laakso M.P., DeCarli C., Beltramello A., Bianchetti A., et al. APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology 1999, 53:1825-1832.
28. Glover G.H., Lai S. Self-navigated spiral fMRI: Interleaved versus single-shot. Magnetic Resonance in Medicine 1998, 39:361-368.
29. Gorno-Tempini M.L., Price C.J. Identification of famous faces and buildings: A functional neuroimaging study of semantically unique items. Brain 2001, 124:2087-2097.
30. Gusnard D.A., Raichle M.E. Searching for a baseline: Functional imaging and the resting human brain. Nature Reviews Neuroscience 2001, 2:685-694.
31. Han S.D., Houston W.S., Jak A.J., Eyler L.T., Nagel B.J., Fleisher A.S., et al. Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiology of Aging 2007, 28:238-247.
32. Hsu Y.Y., Schuff N., Du A.T., Mark K., Zhu X., Hardin D., et al. Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia. Journal of Magnetic Resonance Imaging 2002, 16:305-310.
33. Ivnik R.J., Malec J.F., Smith G.E., Tangalos E.G., Petersen R.C., Kokmen E., et al. Mayo's older Americans normative studies: Update AVLT norms for ages 56 to 97. Clinical Neuropsychologist 1992, 6:83-104.
34. Ivnik R.J., Malec J.F., Smith G.E., Tangalos E.G., Petersen R.C. Neuropsychological Tests' Norms above age 55: COWAT, MAE, BNT Token, WRAT-R Reading, AMNART, STROOP, TNT and JLO. Clinical Neuropsychologist 1996, 10:262-278.
35. Johnson S.C., Schmitz T.W., Moritz C.H., Meyerand M.E., Rowley H.A., Alexander A.L., et al. Activation of brain regions vulnerable to Alzheimer's disease: The effect of mild cognitive impairment. Neurobiology of Aging 2006, 27:1604-1612.
36. Kozauer N.A., Mielke M.M., Chan G.K., Rebok G.W., Lyketsos C.G. Apolipoprotein E genotype and lifetime cognitive decline. International Psychogeriatrics 2008, 20:109-123.
37. Kramer J.H., Rosen H.J., Du A.T., Schuff N., Hollnagel C., Weiner M.W., et al. Dissociations in hippocampal and frontal contributions to episodic memory performance. Neuropsychology 2005, 19:799-805.
38. Landau, S. M., Harvey, D., Madison, C. M., Koeppe, R. A., Reiman, E. M., Foster, N. L., et al. Associations between cognitive, functional, and FDG-PETmeasures of decline in AD and MCI. Neurobiology of Aging, in press, [Epub ahead of print in PubMed]. doi:10.1016/j.neurobiolaging.2009.07.002.
39. Lind J., Larsson A., Persson J., Ingvar M., Nilsson L.G., Backman L., et al. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: Relation to chronological age and recognition memory. Neuroscience Letters 2006, 396:23-27.
40. Lustig C., Snyder A.Z., Bhakta M., O'Brien K.C., McAvoy M., Raichle M.E., et al. Functional deactivations: Change with age and dementia of the Alzheimer type. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:14504-14509.
41. Machulda M.M., Ward H.A., Borowski B., Gunter J.L., Cha R.H., O'Brien P.C., et al. Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology 2003, 61:500-506.
42. McNamara T.P., Shelton A.L. Cognitive maps and the hippocampus. Trends in Cognitive Sciences 2003, 7:333-335.
43. Moscovitch M., Nadel L., Winocur G., Gilboa A., Rosenbaum R.S. The cognitive neuroscience of remote episodic, semantic and spatial memory. Current Opinion in Neurobiology 2006, 16:179-190.
44. Murphy G.M., Taylor J., Kraemer H.C., Yesavage J., Tinklenberg J.R. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease. American Journal of Psychiatry 1997, 154:603-608.
45. Pai M.C., Jacobs W.J. Topographical disorientation in community-residing patients with Alzheimer's disease. International Journal of Geriatric Psychiatry 2004, 19:250-255.
46. Paller K.A., Wagner A.D. Observing the transformation of experience into memory. Trends in Cognitive Sciences 2002, 6:93-102.
47. Persson J., Lind J., Larsson A., Ingvar M., Sleegers K., Van Broeckhoven C., et al. Altered deactivation in individuals with genetic risk for Alzheimer's disease. Neuropsychologia 2008, 46:1679-1687.
48. Petersen R.C., Smith G.E., Ivnik R.J., Tangalos E.G., Schaid D.J., Thibodeau S.N., et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995, 273:1274-1278.
49. Pihlajamaki M., K O.K., Bertram L., Tanzi R.E., Dickerson B.C., Blacker D., et al. Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease. Alzheimer Disease and Associated Disorders 2010, 24:28-36.
50. Pihlajamaki M., Sperling R.A. Functional MRI assessment of task-induced deactivation of the default mode network in Alzheimer's disease and at-risk older individuals. Behavioral Neurology 2009, 21:77-91.
51. Richards B., Skoletsky J., Shuber A.P., Balfour R., Stern R.C., Dorkin H.L., et al. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Human Molecular Genetics 1993, 2:159-163.
52. Rombouts S.A., Barkhof F., Goekoop R., Stam C.J., Scheltens P. Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: An fMRI study. Human Brain Mapping 2005, 26:231-239.
53. Saunders A.M., Schmader K., Breitner J.C., Benson M.D., Brown W.T., Goldfarb L., et al. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993, 342:710-711.
54. Schacter D.L., Wagner A.D. Medial temporal lobe activations in fMRI and PET studies of episodic encoding and retrieval. Hippocampus 1999, 9:7-24.
55. Seltzer B., Pandya D.N. Further observations on parieto-temporal connections in the rhesus monkey. Experimental Brain Research 1984, 55:301-312.
56. Shelton A.L., Gabrieli J.D. Neural correlates of encoding space from route and survey perspectives. Journal of Neuroscience 2002, 22:2711-2717.
57. Shelton A.L., McNamara T.P. Orientation and perspective dependence in route and survey learning. Journal of Experimental Psychology Learning, Memory, and Cognition 2004, 30:158-170.
58. Shelton A.L., Pippitt H.A. Fixed versus dynamic orientations in environmental learning from ground-level and aerial perspectives. Psychological Research 2007, 71:333-346.
59. Small B.J., Rosnick C.B., Fratiglioni L., Backman L. Apolipoprotein E and cognitive performance: A meta-analysis. Psychology and Aging 2004, 19:592-600.
60. Soininen H., Partanen K., Pitkanen A., Hallikainen M., Hanninen T., Helisalmi S., et al. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele. Neurology 1995, 45:391-392.
61. Squire L.R., Stark C.E., Clark R.E. The medial temporal lobe. Annual Review of Neuroscience 2004, 27:279-306.
62. Stark C.E., Squire L.R. When zero is not zero: The problem of ambiguous baseline conditions in fMRI. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:12760-12766.
63. Suzuki W.A., Amaral D.G. Perirhinal and parahippocampal cortices of the macaque monkey: Cortical afferents. Journal of Comparative Neurology 1994, 350:497-533.
64. Tanzi R.E., Bertram L. New frontiers in Alzheimer's disease genetics. Neuron 2001, 32:181-184.
65. Taylor J.L., Kennedy Q., Noda A., Yesavage J.A. Pilot age and expertise predict flight simulator performance: a 3-year longitudinal study. Neurology 2007, 68(9):648-654.
66. Tombaugh T.N., Kozak J., Rees L. Normative Data for the controlled oral word association test. Personal communication cited in Spreen and Strauss. A compendium of neuropsychological tests: Administration, norms and commentary 1996, Oxford University Press, New York. 2nd ed.
67. Tombaugh T.N., Rees L., McIntyre N. Normative data for the Trail Making Test. Personal communication cited in Spreen and Strauss. A compendium of neuropsychological tests: Administration, norms and commentary 1998, Oxford University Press, New York. 2nd ed.
68. Trachtenberg, A. J., Filippini, N., &Mackay, C. E. The effects of APOE-epsilon4 on the BOLD response. Neurobiology of Aging, in press, doi:10.1016/j.neurobiolaging.2010.03.009.
69. Trivedi M.A., Schmitz T.W., Ries M.L., Torgerson B.M., Sager M.A., Hermann B.P., et al. Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: A cross-sectional study. BMC Medicine 2006, 4:1.
70. Wagner A.D., Schacter D.L., Rotte M., Koutstaal W., Maril A., Dale A.M., et al. Building memories: Remembering and forgetting of verbal experiences as predicted by brain activity. Science 1998, 281:1188-1191.
71. Wierenga C.E., Bondi M.W. Use of functional Magnetic Resonance Imaging in the early identification of Alzheimer's disease. Neuropsychology Review 2007, 17:127-143.
72. Wisdom N.M., Callahan J.L., Hawkins K.A. The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis. Neurobiology of Aging 2011, 32:63-74.